Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer. (Q34115068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Daniel T Rein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anne Volkmer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gerd Bauerschmitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Wolfgang Janni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Markus C Fleisch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anne Kathrin Welter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dirk Bauerschlag

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Thomas Schöndorf

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Martina Breidenbach

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

603-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Studies on the use of viruses in the treatment of carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Gene therapy of gynaecological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Gene transfer approaches for gynecological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Current developments in adenovirus-based cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1135-5

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy

21 January 2018

1 reference

12 December 2020

Reversal of drug resistance in ovarian cancer: where do we go from here?

1 reference

12 December 2020

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

1 reference

12 December 2020

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors

1 reference

12 December 2020

Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine

1 reference

12 December 2020

Cancer statistics, 2010

1 reference

12 December 2020

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

1 reference

12 December 2020

Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus

1 reference

12 December 2020

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents

1 reference

12 December 2020

[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus]

1 reference

12 December 2020

ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.

1 reference

12 December 2020

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

12 December 2020

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma

1 reference

12 December 2020

Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.

1 reference

12 December 2020

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

1 reference

12 December 2020

Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel

1 reference

12 December 2020

10.1007/S00432-011-1135-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22209976%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference